96 related articles for article (PubMed ID: 21148032)
21. Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis.
Baumgarten G; Knuefermann P; Wrigge H; Putensen C; Stapel H; Fink K; Meyer R; Hoeft A; Grohé C
Eur J Anaesthesiol; 2006 Dec; 23(12):1041-8. PubMed ID: 16836770
[TBL] [Abstract][Full Text] [Related]
22. TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation.
Na HY; Mazumdar K; Moon HJ; Chang S; Seong SY
Cell Immunol; 2009; 259(1):33-40. PubMed ID: 19559408
[TBL] [Abstract][Full Text] [Related]
23. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
24. A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages.
Chang HH; Yeh CH; Sheu F
J Agric Food Chem; 2009 Jul; 57(14):6129-39. PubMed ID: 19548679
[TBL] [Abstract][Full Text] [Related]
25. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.
Tavener SA; Long EM; Robbins SM; McRae KM; Van Remmen H; Kubes P
Circ Res; 2004 Oct; 95(7):700-7. PubMed ID: 15358664
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
27. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
[TBL] [Abstract][Full Text] [Related]
28. Activation of NLRX1-mediated autophagy accelerates the ototoxic potential of cisplatin in auditory cells.
Yin H; Yang Q; Cao Z; Li H; Yu Z; Zhang G; Sun G; Man R; Wang H; Li J
Toxicol Appl Pharmacol; 2018 Mar; 343():16-28. PubMed ID: 29454061
[TBL] [Abstract][Full Text] [Related]
29. Protective mechanism of Korean Red Ginseng in cisplatin-induced ototoxicity through attenuation of nuclear factor-κB and caspase-1 activation.
Kim SJ; Kwak HJ; Kim DS; Choi HM; Sim JE; Kim SH; Um JY; Hong SH
Mol Med Rep; 2015 Jul; 12(1):315-22. PubMed ID: 25738645
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.
So H; Kim H; Lee JH; Park C; Kim Y; Kim E; Kim JK; Yun KJ; Lee KM; Lee HY; Moon SK; Lim DJ; Park R
J Assoc Res Otolaryngol; 2007 Sep; 8(3):338-55. PubMed ID: 17516123
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
[TBL] [Abstract][Full Text] [Related]
32. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.
Zhang B; Ramesh G; Uematsu S; Akira S; Reeves WB
J Am Soc Nephrol; 2008 May; 19(5):923-32. PubMed ID: 18256356
[TBL] [Abstract][Full Text] [Related]
33. Development of Cell-Based High-Throughput Chemical Screens for Protection Against Cisplatin-Induced Ototoxicity.
Teitz T; Goktug AN; Chen T; Zuo J
Methods Mol Biol; 2016; 1427():419-30. PubMed ID: 27259939
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 4 modulates the cochlear immune response to acoustic injury.
Vethanayagam RR; Yang W; Dong Y; Hu BH
Cell Death Dis; 2016 Jun; 7(6):e2245. PubMed ID: 27253409
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyethyl starch (130 kD) inhibits Toll-like receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide.
Tian J; Wang Y; He Z; Gao Y; Rundhaug JE; Wang X
Anesth Analg; 2011 Jul; 113(1):112-9. PubMed ID: 21415432
[TBL] [Abstract][Full Text] [Related]
36. The role of toll-like receptor 4 in cisplatin-induced renal injury.
Cenedeze MA; Gonçalves GM; Feitoza CQ; Wang PM; Damião MJ; Bertocchi AP; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):409-11. PubMed ID: 17362743
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin Toxicity Is Mediated by Direct Binding to Toll-Like Receptor 4 through a Mechanism That Is Distinct from Metal Allergens.
Domingo IK; Groenendyk J; Michalak M; Bhavsar AP
Mol Pharmacol; 2023 Mar; 103(3):158-165. PubMed ID: 36460345
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity.
Babolmorad G; Latif A; Domingo IK; Pollock NM; Delyea C; Rieger AM; Allison WT; Bhavsar AP
EMBO Rep; 2021 May; 22(5):e51280. PubMed ID: 33733573
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9-mediated knockout of Lim-domain only four retards organ of Corti cell growth.
Rathinam R; Rosati R; Jamesdaniel S
J Cell Biochem; 2018 Apr; 119(4):3545-3553. PubMed ID: 29143984
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-10 Attenuates Hypochlorous Acid-Mediated Cytotoxicity to HEI-OC1 Cochlear Cells.
Mwangi M; Kil SH; Phak D; Park HY; Lim DJ; Park R; Moon SK
Front Cell Neurosci; 2017; 11():314. PubMed ID: 29056901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
